Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits

2001 ◽  
Vol 27 (2) ◽  
pp. 310-319 ◽  
Author(s):  
Ming X Wang ◽  
Trevor B Gray ◽  
Woo Chan Park ◽  
Pinnita Prabhasawat ◽  
William Culbertson ◽  
...  
1998 ◽  
Author(s):  
Ming X. Wang ◽  
Trevor Gray ◽  
Pinnita Prabhasawat ◽  
Xiong Ma ◽  
William Culbertson ◽  
...  

2019 ◽  
Vol 104 (3) ◽  
pp. 341-344 ◽  
Author(s):  
James Myerscough ◽  
Cristina Bovone ◽  
Peter Benjamin Michael Thomas ◽  
Michael Mimouni ◽  
Faisal Aljassar ◽  
...  

Background/AimsTo evaluate the 5-year outcomes of sutureless superficial anterior lamellar keratoplasty (SALK) in the treatment of surface ablation-related corneal haze recurring after phototherapeutic keratectomy (PTK).MethodsProspective interventional study at a tertiary referral centre in Forli, Italy. Ten consecutive eyes with corneal haze following photorefractive keratectomy, recurring after treatment with PTK with or without mitomycin C, undergoing sutureless SALK. Sutureless SALK was performed using a microkeratome in donor and recipient. Main outcome measures: best spectacle-corrected visual acuity (BSCVA), surgically induced astigmatism (SIA), rate of recurrence and complications.ResultsThere were no intraoperative complications and there was no recurrence of haze in any eye postoperatively. BSCVA showed significant improvement at all postoperative time points. Mean preoperative visual acuity improved from 0.46 logMAR units (SD=0.12) to 0.12 (SD=0.12, p=0.0001) at 5 years. At 6 months, SIA was 2.50±1.04 with no further significant change at 5 years (2.53±1.39, p=0.95). There was no significant change in mean spherical equivalent and no significant difference between preoperative and postoperative astigmatism vector values at 5 years.ConclusionsSutureless SALK provides a useful treatment option in patients with recurrent haze after excimer laser treatment. It can eliminate haze recurrence for at least a period of 5 years and can improve BSCVA, although there may be significant SIA.


1995 ◽  
Vol 35 (4) ◽  
pp. 179
Author(s):  
K. Soya ◽  
H. Obata ◽  
S. Amano ◽  
K. Miyata ◽  
T. Tsuru

2008 ◽  
Vol 86 (2) ◽  
pp. 235-240 ◽  
Author(s):  
Rajiv R. Mohan ◽  
W. Michael Stapleton ◽  
Sunilima Sinha ◽  
Marcelo V. Netto ◽  
Steven E. Wilson

2001 ◽  
Vol 40 (10) ◽  
pp. 1727 ◽  
Author(s):  
Juan A. del Val ◽  
Sonia Barrero ◽  
Bety Yáñez ◽  
Jesús Merayo ◽  
Juan A. Aparicio ◽  
...  

2020 ◽  
Author(s):  
Marley J. Dewey ◽  
Eileen M. Johnson ◽  
Simona T. Slater ◽  
Derek J. Milner ◽  
Matthew B. Wheeler ◽  
...  

ABSTRACTDefects in craniofacial bones occur congenitally, after high-energy impacts, and during the course of treatment for stroke and cancer. These injuries are difficult to heal due to the overwhelming size of the injury area and the inflammatory environment surrounding the injury. Significant inflammatory response after injury may greatly inhibit regenerative healing. We have developed mineralized collagen scaffolds that can induce osteogenic differentiation and matrix biosynthesis in the absence of osteogenic media or supplemental proteins. The amniotic membrane is derived from placentas and has been recently investigated as an extracellular matrix to prevent chronic inflammation. Herein, we hypothesized that a mineralized collagen-amnion composite scaffold could increase osteogenic activity in the presence of inflammatory cytokines. We report mechanical properties of a mineralized collagen-amnion scaffold and investigated osteogenic differentiation and mineral deposition of porcine adipose derived stem cells within these scaffolds as a function of inflammatory challenge. Incorporation of amniotic membrane matrix promotes osteogenesis similarly to un-modified mineralized collagen scaffolds, and increases in mineralized collagen-amnion scaffolds under inflammatory challenge. Together, these findings suggest that a mineralized collagen-amnion scaffold may provide a beneficial environment to aid craniomaxillofacial bone repair, especially in the course of defects presenting significant inflammatory complications.


Sign in / Sign up

Export Citation Format

Share Document